Evaluating a new sleep apnea detection device for children

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to collect data and assess algorithms to evaluate the clinical effectiveness of a novel sleep apnea detection system specifically designed for children. Patients referred for suspected sleep apnea will participate by spending a night in the clinic, where they will use both the new device and the standard polysomnography system. The study will compare the diagnostic results from both systems to determine the efficacy of the novel device in diagnosing sleep apnea in the pediatric population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Children older than one year old
* Children who have been referred to a sleep clinic due to suspicion of sleep apnoea.

Exclusion Criteria:

* Patients whose parents/legal guardians/carers are not fluent in English, or who have special communication needs.
* Known allergy to the adhesive dressing.
* Patients with physical or mental impairments who would be too distressed with additional sensors on themselves.
* Patients with not enough space on the neck area to fit the sensor.
* Clinical problem in the area in which the device will be attached, eg skin condition

Where it's running

• Sheffield Children Hospital
  Sheffield, United Kingdom Recruiting
• Southampton Children's Hospital
  Southampton, United Kingdom Recruiting

Study contacts

• Study coordinator: Orsina Dessi, MEng
• Email: orsina@acurable.com
• Phone: +447721 877020

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Oura Ring validation for sleep using gold-standard sleep tests

  This study tests how well the Oura Ring matches the gold-standard sleep test ( PSG ) in healthy adults and people with sleep apnea.

  Recruiting Ouraring Inc. · St Louis, Missouri · NCT07908199

• Left-atrial Fibrosis in Persistent Atrial Fibrillation and Its Comorbidities

  This study tests how comorbid conditions like sleep apnea and primary aldosteronism relate to left-atrial fibrosis and AF recurrence in patients undergoing ablation.

  Recruiting University Hospital Augsburg · Augsburg, Bavaria · NCT07857044

• Using a sleep medication to help people with obstructive sleep apnea tolerate CPAP

  The trial will test whether giving the sleep medicine eszopiclone to people with obstructive sleep apnea (AHI ≥10/hour) helps them stick with CPAP and improves thinking skills.

  Recruiting Phase 3 Yale University · North Haven, Connecticut · NCT07332442

• Neurostimulation treatment for sleep-disordered breathing

  This trial will test whether the Lunair Alpha System, a small implanted neurostimulator, can reduce breathing problems during sleep for people with moderate to severe sleep apnea who cannot tolerate or access other treatments.

  Recruiting Lunair Medical · Panama City, Provincia de Panamá · NCT07243405

• IBI362 for Chinese adults with obstructive sleep apnea and BMI ≥28

  This trial will see if once-weekly IBI362 injections help Chinese adults with moderate-to-severe obstructive sleep apnea who have a BMI of 28 or higher.

  Recruiting Phase 3 Innovent Biologics (Suzhou) Co. Ltd. · Beijing · NCT06931028

• Neurostimulation treatment for sleep apnea

  This study tests a new implant that uses neurostimulation to see if it can help people with moderate to severe sleep apnea who can't use regular treatments.

  Recruiting Lunair Medical · Asunción, Paraguay · NCT06883617

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.